113 related articles for article (PubMed ID: 33099901)
1. Adding perphenazine to increase effectiveness of standard glioblastoma chemoirradiation.
Kast RE
J BUON; 2020; 25(4):1676-1686. PubMed ID: 33099901
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma treatment using perphenazine to block the subventricular zone's tumor trophic functions.
Kast RE; Ellingson BM; Marosi C; Halatsch ME
J Neurooncol; 2014 Jan; 116(2):207-12. PubMed ID: 24242756
[TBL] [Abstract][Full Text] [Related]
3. Adding high-dose celecoxib to increase effectiveness of standard glioblastoma chemoirradiation.
Kast RE
Ann Pharm Fr; 2021 Sep; 79(5):481-488. PubMed ID: 33689795
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic profile of perphenazine's metabolites.
Sweet RA; Pollock BG; Mulsant BH; Rosen J; Sorisio D; Kirshner M; Henteleff R; DeMichele MA
J Clin Psychopharmacol; 2000 Apr; 20(2):181-7. PubMed ID: 10770456
[TBL] [Abstract][Full Text] [Related]
5. Perphenazine Attenuates the Pro-Inflammatory Responses in Mouse Models of Th2-Type Allergic Dermatitis.
Heo MJ; Choi SY; Lee C; Choi YM; An IS; Bae S; An S; Jung JH
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375285
[TBL] [Abstract][Full Text] [Related]
6. Perphenazine and prochlorperazine induce concentration-dependent loss in human glioblastoma cells viability.
Otręba M; Buszman E
Pharmazie; 2018 Jan; 73(1):19-21. PubMed ID: 29441946
[TBL] [Abstract][Full Text] [Related]
7. In vitro anticancer activity of fluphenazine, perphenazine and prochlorperazine. A review.
Otręba M; Kośmider L
J Appl Toxicol; 2021 Jan; 41(1):82-94. PubMed ID: 32852120
[TBL] [Abstract][Full Text] [Related]
8. Anti-emetic efficacy of prophylactic granisetron compared with perphenazine for the prevention of post-operative vomiting in children.
Fujii Y; Saitoh Y; Tanaka H; Toyooka H
Eur J Anaesthesiol; 1999 May; 16(5):304-7. PubMed ID: 10390665
[TBL] [Abstract][Full Text] [Related]
9. Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients.
Gunes A; Scordo MG; Jaanson P; Dahl ML
Psychopharmacology (Berl); 2007 Mar; 190(4):479-84. PubMed ID: 17102980
[TBL] [Abstract][Full Text] [Related]
10. Effect of perphenazine enanthate in Pyrenean chamois (Rupicapra pyrenaica).
Marco I; Cabezón O; Mentaberre G; Fernández-Sirera L; Casas-Díaz E; Fernandez-Aguilar X; López-Olvera JR; Serrano E; Navarro-Gonzalez N; Lavín S; Manteca X
J Zoo Wildl Med; 2013 Dec; 44(4):1083-5. PubMed ID: 24450074
[TBL] [Abstract][Full Text] [Related]
11. Treatment of secondary depression in schizophrenia. A double-blind, placebo-controlled trial of amitriptyline added to perphenazine.
Prusoff BA; Williams DH; Weissman MM; Astrachan BM
Arch Gen Psychiatry; 1979 May; 36(5):569-75. PubMed ID: 373665
[TBL] [Abstract][Full Text] [Related]
12. Controlling conditioning-related emesis in children undergoing bone marrow transplantation.
Mehta NH; Reed CM; Kuhlman C; Weinstein HJ; Parsons SK
Oncol Nurs Forum; 1997 Oct; 24(9):1539-44. PubMed ID: 9348595
[TBL] [Abstract][Full Text] [Related]
13. The effects of perphenazine and bromocriptine on follicular dynamics and endocrine profiles in anestrous pony mares.
Bennett-Wimbush K; Loch WE; Plata-Madrid H; Evans T
Theriogenology; 1998 Mar; 49(4):717-33. PubMed ID: 10732080
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic antagonists potentiate the adenohypophyseal growth reaction to oestrogen: thioridazine is less effective than perphenazine.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1987; 36(1):9-13. PubMed ID: 2884683
[TBL] [Abstract][Full Text] [Related]
15. CYP2D6 genotype in relation to perphenazine concentration and pituitary pharmacodynamic tissue sensitivity in Asians: CYP2D6-serotonin-dopamine crosstalk revisited.
Ozdemir V; Bertilsson L; Miura J; Carpenter E; Reist C; Harper P; Widén J; Svensson JO; Albers LJ; Kennedy JL; Endrenyi L; Kalow W
Pharmacogenet Genomics; 2007 May; 17(5):339-47. PubMed ID: 17429316
[TBL] [Abstract][Full Text] [Related]
16. Perphenazine for schizophrenia.
Hartung B; Wada M; Laux G; Leucht S
Cochrane Database Syst Rev; 2005 Jan; (1):CD003443. PubMed ID: 15674907
[TBL] [Abstract][Full Text] [Related]
17. Antiemetic effect of perphenazine versus prochlorperazine intravenously before cisplatin therapy.
Smaglia RA; Parkinson DR; Taylor CD
Clin Pharm; 1984; 3(1):68-71. PubMed ID: 6365417
[TBL] [Abstract][Full Text] [Related]
18. [Perphenazine as an activating phenothiazine].
Mäkelä S
Nord Psykiatr Tidsskr; 1966; 20(3):208-20. PubMed ID: 5965589
[No Abstract] [Full Text] [Related]
19. BL-1020, an oral antipsychotic agent that reduces dopamine activity and enhances GABAA activity, for the treatment of schizophrenia.
Fitzgerald PB
Curr Opin Investig Drugs; 2010 Jan; 11(1):92-100. PubMed ID: 20047163
[TBL] [Abstract][Full Text] [Related]
20. Late Reduction of Cocaine Cravings in a Randomized, Double-Blind Trial of Aripiprazole vs Perphenazine in Schizophrenia and Comorbid Cocaine Dependence.
Beresford T; Buchanan J; Thumm EB; Emrick C; Weitzenkamp D; Ronan PJ
J Clin Psychopharmacol; 2017 Dec; 37(6):657-663. PubMed ID: 28984746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
